State Street Corp Cue Biopharma, Inc. Transaction History

State Street Corp

$2.25 Trillion
Q2 2024

A detailed history of State Street Corp transactions in Cue Biopharma, Inc. stock. As of the latest transaction made, State Street Corp holds 177,053 shares of CUE stock, worth $120,396. This represents 0.0% of its overall portfolio holdings.

Number of Shares

177,053

Previous 759,795 76.7%

Holding current value

$120,396

Previous $1.44 Million 84.75%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.24 - $2.18 $722,600 - $1.27 Million	-582,742 Reduced 76.7%	177,053 $219,000
Q1 2024 May 15, 2024	BUY	$1.77 - $3.09 $134,697 - $235,149	76,100 Added 11.13%	759,795 $1.44 Million
Q4 2023 Feb 14, 2024	SELL	$1.72 - $3.1 $24,940 - $44,950	-14,500 Reduced 2.08%	683,695 $1.8 Million
Q3 2023 Nov 14, 2023	BUY	$2.23 - $4.69 $104,587 - $219,961	46,900 Added 7.2%	698,195 $1.61 Million
Q2 2023 Aug 14, 2023	BUY	$3.11 - $4.91 $1.59 Million - $2.5 Million	510,142 Added 361.41%	651,295 $2.38 Million
Q3 2022 Nov 15, 2022	SELL	$2.23 - $3.37 $38,915 - $58,809	-17,451 Reduced 11.0%	141,153 $315,000
Q2 2022 Aug 15, 2022	SELL	$2.49 - $5.92 $1.42 Million - $3.37 Million	-568,419 Reduced 78.18%	158,604 $395,000
Q1 2022 May 16, 2022	SELL	$4.41 - $12.28 $4.12 Million - $11.5 Million	-935,229 Reduced 56.26%	727,023 $3.55 Million
Q4 2021 Feb 14, 2022	BUY	$10.86 - $17.85 $3.86 Million - $6.35 Million	355,806 Added 27.23%	1,662,252 $18.8 Million
Q3 2021 Nov 15, 2021	SELL	$10.06 - $15.3 $1.65 Million - $2.5 Million	-163,629 Reduced 11.13%	1,306,446 $19 Million
Q2 2021 Aug 16, 2021	BUY	$10.9 - $14.53 $1.08 Million - $1.45 Million	99,470 Added 7.26%	1,470,075 $17.1 Million
Q1 2021 May 17, 2021	SELL	$11.2 - $16.09 $234,897 - $337,455	-20,973 Reduced 1.51%	1,370,605 $16.7 Million
Q4 2020 Feb 16, 2021	BUY	$11.12 - $16.4 $426,040 - $628,333	38,313 Added 2.83%	1,391,578 $17.4 Million
Q3 2020 Nov 10, 2020	BUY	$15.05 - $23.54 $4.91 Million - $7.68 Million	326,384 Added 31.78%	1,353,265 $20.4 Million
Q2 2020 Aug 14, 2020	BUY	$12.7 - $30.73 $8.32 Million - $20.1 Million	655,098 Added 176.2%	1,026,881 $25.2 Million
Q1 2020 May 11, 2020	BUY	$9.85 - $22.27 $3.66 Million - $8.28 Million	371,783 New	371,783 $5.28 Million

Others Institutions Holding CUE

# of Institutions

Shares Held

13.8M

Call Options Held

56.1K

Put Options Held

11.1K

View Full List

About Cue Biopharma, Inc.

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $24.1M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

More about CUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Cue Biopharma, Inc. Transaction History